Australia's Mach7 Technologies climbs on upbeat revenue outlook

Mach7 Technologies

21/07/2022 01:58

** Shares of medical imaging systems provider Mach7
Technologies  M7T.AX  rise as much as 11.9% to A$0.800, their
highest since March 25
    ** Co expects FY22 revenue to be in range of A$26.5 mln to
A$27.5 mln ($18.26 mln-$18.94 mln), higher than A$19.1 mln
reported in FY21  urn:newsml:reuters.com:*:nASX5KHVB1
    ** Says FY22 sales orders stood at A$33.2 mln, up 30%
year-on-year
    ** Says FY23 sales orders target is expected to be around
A$36 mln
    ** Shares mark their biggest intraday gain since July 13
    ** Volumes 1.5 times the 30-day average of 190,028 shares
    ** As of last close, stock down 12.8% this year

    ($1 = 1.4516 Australian dollars)

 (Reporting by Himanshi Akhand in Bengaluru)
 ((Himanshi.Akhand@thomsonreuters.com;))